表紙
市場調查報告書

正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估

Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 358892
出版日期 內容資訊 英文 82 Pages
訂單完成後即時交付
價格
Back to Top
正子斷層掃描 (PET) 設備的全球市場:醫療設備的開發平台評估 Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年05月01日內容資訊: 英文 82 Pages
簡介

本報告提供全球正子斷層掃描 (以下簡稱PET) 系統市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的各進展階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 正子斷層掃描 (PET) 系統概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • PET設備的企業:各臨床實驗階段的開發中產品
  • PET設備:各臨床實驗階段的開發中產品

第5章 PET設備市場:企業·產品概要

  • Brain Biosciences Inc
    • 開發中產品及進行中的臨床實驗概要
  • GE Healthcare Limited
  • Jagiellonian University
  • Philips Healthcare
  • Ray Vision Intl Corp.
  • Stanford University
  • SynchroPET
  • The University of British Columbia
  • Zecotek Photonics Inc.

第6章 PET設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0767EPD

GlobalData's Medical Devices sector report, "Positron Emission Tomography (PET) Systems - Medical Devices Pipeline Assessment, 2019" provides an overview of Positron Emission Tomography (PET) Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Positron Emission Tomography (PET) Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Positron Emission Tomography (PET) Systems under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Positron Emission Tomography (PET) Systems and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Positron Emission Tomography (PET) Systems under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

  • 2.1 Positron Emission Tomography (PET) Systems Overview

3 Products under Development

  • 3.1 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • 3.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • 3.3 Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • 3.4 Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date

4 Positron Emission Tomography (PET) Systems - Pipeline Products under Development by Companies

  • 4.1 Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • 4.2 Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development

5 Positron Emission Tomography (PET) Systems Companies and Product Overview

  • 5.1 Brain Biosciences Inc Company Overview
  • 5.2 GE Healthcare LLC Company Overview
  • 5.3 General De Equipment for Medical Imaging SA Company Overview
  • 5.4 Jagiellonian University Company Overview
  • 5.5 Lightpoint Medical Ltd Company Overview
  • 5.6 Neurovation Labs Inc Company Overview
  • 5.7 Nuclear, Plasma, and Radiological Engineering Company Overview
  • 5.8 Philips Healthcare Company Overview
  • 5.9 Ray Vision Intl Corp. Company Overview
  • 5.10 Stanford University Company Overview
  • 5.11 SynchroPET Company Overview
  • 5.12 University of British Columbia Company Overview
  • 5.13 University of Washington Company Overview
  • 5.14 West Virginia University Company Overview

6 Positron Emission Tomography (PET) Systems- Recent Developments

  • 6.1 Mar 25, 2019: Inflazome receives funding from The Michael J. Fox Foundation for Parkinson's Research
  • 6.2 Mar 18, 2019: European Association of Urology issues updated guidelines for prostate cancer imaging

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

1.1 List of Tables

  • Table 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Table 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Table 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
  • Table 5: Positron Emission Tomography (PET) Systems Companies - Pipeline Products by Stage of Development
  • Table 6: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Table 7: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: CerePET - Product Status
  • Table 9: CerePET - Product Description
  • Table 10: FREEMotion - Product Status
  • Table 11: FREEMotion - Product Description
  • Table 12: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Q.Clear - Product Status
  • Table 14: Q.Clear - Product Description
  • Table 15: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: CareMiBrain - Product Status
  • Table 17: CareMiBrain - Product Description
  • Table 18: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Positron Emission Tomography System - Product Status
  • Table 20: Positron Emission Tomography System - Product Description
  • Table 21: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: HARLI - Product Status
  • Table 23: HARLI - Product Description
  • Table 24: Neurovation Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: NVL1 Diagnostic Tracer - Product Status
  • Table 26: NVL1 Diagnostic Tracer - Product Description
  • Table 27: Nuclear, Plasma, and Radiological Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Head And Neck PET System - Product Status
  • Table 29: Head And Neck PET System - Product Description
  • Table 30: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Additional PET Scan - Product Status
  • Table 32: Additional PET Scan - Product Description
  • Table 33: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Helmet - PET System - Product Status
  • Table 35: Helmet - PET System - Product Description
  • Table 36: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Breast-Dedicated PET System - Product Status
  • Table 38: Breast-Dedicated PET System - Product Description
  • Table 39: Dual Panel PET Scanner - Product Status
  • Table 40: Dual Panel PET Scanner - Product Description
  • Table 41: Dual-isotope Positron Emitting Tomography System - Product Status
  • Table 42: Dual-isotope Positron Emitting Tomography System - Product Description
  • Table 43: MR Compatible PET System - Product Status
  • Table 44: MR Compatible PET System - Product Description
  • Table 45: Next Generation TOF-PET System - Product Status
  • Table 46: Next Generation TOF-PET System - Product Description
  • Table 47: PET Sensitivity Enhancing Device - Product Status
  • Table 48: PET Sensitivity Enhancing Device - Product Description
  • Table 49: PET System - Product Status
  • Table 50: PET System - Product Description
  • Table 51: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Arterial PET Scanner - Product Status
  • Table 53: Arterial PET Scanner - Product Description
  • Table 54: Breast PET-MRI - Product Status
  • Table 55: Breast PET-MRI - Product Description
  • Table 56: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: PET Imaging Tool - Product Status
  • Table 58: PET Imaging Tool - Product Description
  • Table 59: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: DS-PS3 Positron Emission Tomography Detector - Product Status
  • Table 61: DS-PS3 Positron Emission Tomography Detector - Product Description
  • Table 62: High Resolution PET Detector - Product Status
  • Table 63: High Resolution PET Detector - Product Description
  • Table 64: PET-Mammogram-Biopsy System - Product Status
  • Table 65: PET-Mammogram-Biopsy System - Product Description
  • Table 66: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 67: Positron Emission Tomography (PET) Imager - Product Status
  • Table 68: Positron Emission Tomography (PET) Imager - Product Description
  • Table 69: Glossary

1.2 List of Figures

  • Figure 1: Positron Emission Tomography (PET) Systems - Pipeline Products by Stage of Development
  • Figure 2: Positron Emission Tomography (PET) Systems - Pipeline Products by Territory
  • Figure 3: Positron Emission Tomography (PET) Systems - Pipeline Products by Regulatory Path
  • Figure 4: Positron Emission Tomography (PET) Systems - Pipeline Products by Estimated Approval Date
Back to Top